Managing a radiotherapy center safely and efficiently using risk-adaptive strategies during coronavirus disease pandemic: Experience from national cancer center of china
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), previously known as the novel coronavirus that causes coronavirus disease 2019 (COVID-19) emerged in December 2019 and spread worldwide. The World Health Organization declared this pandemic outbreak a global public health emergency, and as of April 7, 2020, 1,282,931 cases and 72,774 deaths have been reported in 211 countries.[1] Approximately 18 million cases of cancer are diagnosed worldwide annually;[2] thus, treating and simultaneously protecting these patients against SARS-CoV-2 infection is a challenge.
Source: Radiotherapy and Oncology - Category: Radiology Authors: Nan Bi, Junlin Yi, Jianrong Dai, Shulian Wang, Zongmei Zhou, Kuo Men, Jing Jin, Shugeng Gao, Yexiong Li, Jie He Tags: COVID-19 Rapid Letter Source Type: research
More News: Cancer | Cancer & Oncology | China Health | Coronavirus | COVID-19 | Emergency Medicine | International Medicine & Public Health | Outbreaks | Pandemics | Radiology | Respiratory Medicine | SARS | WHO